|
| 2-Fluoroadenosine Basic information |
| 2-Fluoroadenosine Chemical Properties |
Melting point | 240 °C (D)(lit.) | Boiling point | 747.3±70.0 °C(Predicted) | density | 2.17±0.1 g/cm3(Predicted) | refractive index | -72 ° (C=0.1, EtOH) | storage temp. | Keep in dark place,Sealed in dry,Room Temperature | solubility | DMSO (Slightly, Sonicated), Methanol (Slightly, Heated, Sonicated) | form | Solid | pka | 13.05±0.70(Predicted) | color | Off-White | InChI | InChI=1S/C10H12FN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6-,9-/m1/s1 | InChIKey | HBUBKKRHXORPQB-UUOKFMHZSA-N | SMILES | OC[C@H]1O[C@@H](N2C3C(=C(N=C(F)N=3)N)N=C2)[C@H](O)[C@@H]1O | CAS DataBase Reference | 146-78-1(CAS DataBase Reference) |
Hazard Codes | Xn | Risk Statements | 22-36/37/38 | Safety Statements | 26 | WGK Germany | 3 | RTECS | AU7386000 | HS Code | 29349990 | Toxicity | mouse,LD10,unreported,1000ug/kg (1mg/kg),Progress in Medical Chemistry. Vol. 7, Pg. 69, 1970. |
| 2-Fluoroadenosine Usage And Synthesis |
Description | 2-Fluoroadenosine (F-Ado) was developed at Southern Research Institute in 1957 as a potential anticancer drug. 2-Fluoroadenosine is not deaminated by adenosine deaminase but metabolized to triphosphate as shown in vitro. The drug was also shown to be a potent inhibitor of lymphocyte-mediated cytolysis. | Uses | 2-Fluoroadenosine is a fluorinated analog of Adenoside nucleotide. It is used as an intermediate for the drug fludarabine. Fludarabine is a purine analogue and antineoplastic agent. It is a chemotherapy medication used in the treatment of leukemia and lymphoma. | Definition | ChEBI: 2-fluoroadenosine is a member of adenosines and an organofluorine compound. |
| 2-Fluoroadenosine Preparation Products And Raw materials |
|